Amphastar Pharmaceuticals, Inc. (AMPH) Gross profit 2016–2025
Amphastar Pharmaceuticals, Inc. (AMPH) annual gross profit history from SEC filings — each fiscal year as reported.
$356.1MFY2025 · since FY2016: $104.2M → $356.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $356.1M | -4.8% |
| FY2024 | $373.9M | +6.5% |
| FY2023 | $351.1M | +41.1% |
| FY2022 | $248.9M | +24.6% |
| FY2021 | $199.7M | +39.3% |
| FY2020 | $143.3M | +8.7% |
| FY2019 | $131.9M | +23.3% |
| FY2018 | $107.0M | +18.2% |
| FY2017 | $90.5M | -13.1% |
| FY2016 | $104.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More AMPH financial trends
AMPH RevenueAMPH Net incomeAMPH Net marginAMPH Gross marginAMPH Operating incomeAMPH Operating marginAMPH Operating cash flowAMPH Free cash flowAMPH Capital expendituresAMPH Return on equityAMPH Stock buybacksAMPH Dividends paidAMPH Total assetsAMPH Total liabilitiesAMPH Shareholders’ equityAMPH overview →